\-\ Texto\\:\\ \ \(0\)\
\-\ negative\ \(599\)\
\-\ surgery\ \(977\)\
\-\ \\â\\€\\¢\\ enhancing\\ lesion\\ right\\ occipital\\ lobe\\ with\\ surrounding\\ vasogenic\\ edema\\.\ \(0\)\
\-\ \\â\\€\\¢\\ no\\ cystic\\ component\\.\ \(0\)\
\-\ juvenile\\ pilocytic\\ astrocytoma\ \(4\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ astrocytoma\\ \\-\\ diffuse\\ \\-\\ grade\\ 4\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytoma\\ \\-\\ circumscribed\\ \\-\\ grade\\ 1\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ 11\\ year\\ old\\ girl\\ being\\ treated\\ for\\ cystic\\ fibrosis\\ since\\ birth\\.\\ \\ presents\\ to\\ er\\ with\\ first\\ time\\ seizure\ \(0\)\
\-\ it\\ is\\ interesting\\ that\\ this\\ patient\\ with\\ cystic\\ fibrosis\\ also\\ has\\ an\\ jpa\\.\\ \\ there\\ is\\ no\\ known\\ casual\\ relationship\\ between\\ these\\ two\\ diseases\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.12608161449622085\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.11442586891976883\ \(0\)\
\-\ casual\\:\\ 0\\.09336058900467302\ \(0\)\
\-\ fibrosis\\:\\ 0\\.08746857769816649\ \(0\)\
\-\ cystic\\:\\ 0\\.08498733473281926\ \(0\)\
\-\ \\-\\:\\ 0\\.08421740040038453\ \(0\)\
\-\ jpa\\:\\ 0\\.08282851162680917\ \(0\)\
\-\ grade\\:\\ 0\\.07482383432071196\ \(0\)\
\-\ relationship\\:\\ 0\\.058366078226242867\ \(0\)\
\-\ interesting\\:\\ 0\\.05809561273876937\ \(0\)\
\-\ juvenile\\:\\ 0\\.053524544144906046\ \(0\)\
\-\ vasogenic\\:\\ 0\\.053170846918851405\ \(0\)\
\-\ pilocytic\\:\\ 0\\.05170149782103665\ \(0\)\
\-\ diseases\\:\\ 0\\.049478838131605155\ \(0\)\
\-\ birth\\:\\ 0\\.04719526692705936\ \(0\)\
\-\ occipital\\:\\ 0\\.04582993892717468\ \(0\)\
\-\ 11\\:\\ 0\\.04494532925894332\ \(0\)\
\-\ component\\:\\ 0\\.04486050043943042\ \(0\)\
\-\ ependymoma\\:\\ 0\\.0439665038757214\ \(0\)\
\-\ circumscribed\\:\\ 0\\.043657914794845674\ \(0\)\
\-\ seizure\\:\\ 0\\.04343179105233183\ \(0\)\
\-\ er\\:\\ 0\\.037680277666068525\ \(0\)\
\-\ since\\:\\ 0\\.03607775427239329\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03527948544168213\ \(0\)\
\-\ girl\\:\\ 0\\.034533073919422966\ \(0\)\
\-\ being\\:\\ 0\\.03422744800920182\ \(0\)\
\-\ first\\:\\ 0\\.03295957971018221\ \(0\)\
\-\ surrounding\\:\\ 0\\.03228925591223868\ \(0\)\
\-\ between\\:\\ 0\\.031132132600278663\ \(0\)\
\-\ known\\:\\ 0\\.031081046947859996\ \(0\)\
\-\ enhancing\\:\\ 0\\.03080406359637654\ \(0\)\
\-\ diffuse\\:\\ 0\\.029735717475578332\ \(0\)\
\-\ treated\\:\\ 0\\.02940058432280298\ \(0\)\
\-\ negative\\:\\ 0\\.029334714498561773\ \(0\)\
\-\ two\\:\\ 0\\.0281302441105288\ \(0\)\
\-\ edema\\:\\ 0\\.027780729763578055\ \(0\)\
\-\ time\\:\\ 0\\.02774254284183118\ \(0\)\
\-\ 4\\:\\ 0\\.02736749316297753\ \(0\)\
\-\ lobe\\:\\ 0\\.02642902698762683\ \(0\)\
\-\ these\\:\\ 0\\.025561433240894712\ \(0\)\
\-\ metastatic\\:\\ 0\\.024725395443863107\ \(0\)\
\-\ surgery\\:\\ 0\\.023850563958164078\ \(0\)\
\-\ 1\\:\\ 0\\.023371567447812724\ \(0\)\
\-\ it\\:\\ 0\\.022078717063597892\ \(0\)\
\-\ multiple\\:\\ 0\\.02068742532734792\ \(0\)\
\-\ presents\\:\\ 0\\.020064876959861217\ \(0\)\
\-\ lesion\\:\\ 0\\.020006381908051204\ \(0\)\
\-\ no\\:\\ 0\\.019780325303535677\ \(0\)\
\-\ also\\:\\ 0\\.019363443605404037\ \(0\)\
\-\ has\\:\\ 0\\.018444827247060664\ \(0\)\
\-\ that\\:\\ 0\\.016965295730561186\ \(0\)\
\-\ disease\\:\\ 0\\.01605445449673223\ \(0\)\
\-\ there\\:\\ 0\\.014617420189252743\ \(0\)\
\-\ an\\:\\ 0\\.013582354761893446\ \(0\)\
\-\ is\\:\\ 0\\.012926224790453463\ \(0\)\
\-\ this\\:\\ 0\\.011047554176024517\ \(0\)\
\-\ year\\:\\ 0\\.010989715738769135\ \(0\)\
\-\ right\\:\\ 0\\.010363582863338123\ \(0\)\
\-\ old\\:\\ 0\\.010056719504163847\ \(0\)\
\-\ patient\\:\\ 0\\.009845884263406757\ \(0\)\
\-\ for\\:\\ 0\\.008380553432674886\ \(0\)\
\-\ to\\:\\ 0\\.004908828832678003\ \(0\)\
\-\ with\\:\\ 0\\.004034626761720336\ \(0\)\
\-\ \\.\\:\\ 0\\.002040203223985418\ \(0\)\
